Search - tctmd.com

Displaying 21 - 40 of 101

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2024

Shelley Wood

April 30, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Todd Neale

March 11, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

GDMT Rates Low in HFrEF, Particularly in Women

L.A. McKeown

January 30, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Features

FDA Clears AI-ECG Screening Tools for CV Care: What’s Next Is Up for Grabs

Yael L. Maxwell

December 14, 2023

News Daily News

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

L.A. McKeown

December 08, 2023

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

L.A. McKeown

December 01, 2023

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Conference News HFSA 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Yael L. Maxwell

October 16, 2023

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

L.A. McKeown

September 01, 2023

News Conference News ESC Heart Failure 2023

SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms

L.A. McKeown

June 06, 2023

News Conference News ESC Heart Failure 2023

Boosting GDMT and Improving Outcomes? No Mean Task After AHF

Shelley Wood

June 01, 2023

News Daily News

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

Shelley Wood

May 30, 2023

News Daily News

FDA Extends Dapagliflozin Indication Across LVEF Spectrum

Shelley Wood

May 09, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

News Daily News

AHA/ACC Scientific Statement Supports Exercise Therapy in HFpEF

L.A. McKeown

March 27, 2023

News Daily News

Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives

L.A. McKeown

March 24, 2023

Advertisement

TCTMD’s Top 10 Most Popular Stories for April 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

March 2024 Dispatch for the CV Team

GDMT Rates Low in HFrEF, Particularly in Women

January 2024 Dispatch for the CV Team

FDA Clears AI-ECG Screening Tools for CV Care: What’s Next Is Up for Grabs

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

December 2023 Dispatch for the CV Team

November 2023 News Roundup

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms

Boosting GDMT and Improving Outcomes? No Mean Task After AHF

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

FDA Extends Dapagliflozin Indication Across LVEF Spectrum

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

AHA/ACC Scientific Statement Supports Exercise Therapy in HFpEF

Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content